TipRanks
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market
6BG
Lytix Biopharma AS
RESEARCH TOOLSreports

Lytix Biopharma AS (6BG) Cash flow

3 Followers

Lytix Biopharma AS Cash Flow

DE:6BG's free cash flow for Q2 2026 was kr-28.54M. For the 2026 fiscal year, DE:6BG's free cash flow was decreased by kr10.52M and operating cash flow was kr-28.79M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -57.53Mkr -70.37Mkr -95.97Mkr -52.63Mkr -44.61M
Investing Cash Flow
kr -61.76Mkr 24.69Mkr 29.73Mkr -49.35Mkr 138.00K
Financing Cash Flow
kr -901.00Kkr 149.10Mkr -943.00Kkr -749.00Kkr 213.30M
End Cash Position
kr 10.60Mkr 130.79Mkr 27.36Mkr 94.55Mkr 197.28M
Free Cash Flow
kr -59.85Mkr -70.37Mkr -96.02Mkr -52.78Mkr -44.61M
Currency in NOK

Lytix Biopharma AS Cash Flow